.. |A|         replace:: Ã…

#############
Tutorials
#############

These are tutorials for how to use specific floes.

Short Trajectory MD with Analysis
=================================

The Floe *Short Trajectory MD with Analysis* (STMD) is for pose validation.
You should start with a ligand with one or more conformers already well posed
in the active site, with protein-ligand interactions in place, serving as
hypotheses for ligand binding.
Each pose will be evaluated by this floe to be validated (or not) as a good pose.
We are not primarily asking the question "what is the pose for this ligand?"
but rather "is this a good pose for this ligand?", or with multiple poses,
"which of these poses is best?". We seek an answer by running a
short MD trajectory on each pose separately and comparing the results to the
starting (input) pose and between the poses (if more than one).

What this Floe does
-------------------
The structure of the STMD floe is shown in figure
`Structure of the STMD floe`.
Given the inputs of the protein and posed ligands,
the complex is formed with each ligand/conformer separately,
and the complex is solvated and parametrized according to
the selected force fields.
We refer to this ready-to-run molecular assembly as a "flask"
by analogy to experiment: all the components are combined into
the flask, upon which we run our experiment.
A minimization stage is performed on the flask followed by
a warm up (NVT ensemble) and several equilibration stages (NPT ensemble).
In the minimization, warm up, and equilibration stages,
positional harmonic restraints are applied on the ligand and protein.
At the end of the equilibration stages a short (default 2ns) production run
is performed on the unrestrained flask.
The production run is then analyzed in terms of interactions between
the ligand and the active site and in terms of ligand RMSD,
after fitting the trajectory based on active site C_alphas.

.. figure_STMD_floe:

.. figure:: ./images/STMD_floe.png
   :width: 800px
   :align: center
   :alt: Structure of the STMD floe

   **Structure of the STMD floe**


Ligand Input
------------

Just to be able to run, this floe requires ligands to have
reasonable 3D coordinates, all atoms, and correct chemistry
(in particular bond orders and formal charges).
If the ligands already have good atomic partial charges
(we recommend RESP or AM1-BCC_ELF10 charges),
we recommend using these for STMD as opposed to re-charging
them in the STMD floe.
Given that this floe only runs a very short timescale (default 2 ns),
it is preferable that the input pose be well refined.
Although bad clashes
(or poor positioning for interactions which you know are important)
can be (and often are) cleaned up by even this short trajectory,
it starts off the "evaluation" purpose of the floe on the wrong foot
by giving a poor comparator.
Poor initial poses might even be considered outside the scope of this floe
given how short is the default timescale.
This is why we **strongly recommend** that docked poses be
subsequently minimized in the active site **before input to STMD**.
This will resolve high gradients
(usually clashes) with the protein and to allow protein-ligand
interactions to optimize in the context of a good force field.
It is possible that even with this pre-MD refinement,
the docked-pose starting points could be re-evaluated and
triaged prior to the extra effort and expense of STMD.
The ligand input datasets used in this tutorial are:

    * MCL1_1poseLig35_elf10.oeb
    * MCL1_6poseLig35_elf10.oeb

Protein Input
-------------
All the MD floes require correctly prepared protein up to "MD ready" standards.
This begins with the normal prerequisites for physics-based modeling:
protein chains must be capped,
all atoms in protein residues (including hydrogens) must be present, and missing
protein loops resolved or capped.
Of course, protein side chain formal charges and protonation
at this point determine their tautomeric state.
Additionally, cofactors and structured internal waters are also important to include,
not only those in the immediate vicinity of the ligand and active site
but also distally because they can have an important effect on the
protein structure and dynamics over the course of the MD.
We **strongly recommend** using *Spruce* for protein preparation.
The protein input dataset used in this tutorial is:

    * MCL1_SchrodingerFEP_4HW3A_extprot_v2.oeb.gz

.. warning::

   Unfortunately, proteins with covalently bound ligands or covalently bound cofactors are currently not tractable

How to use this floe
--------------------

After selecting the *Short Trajectory MD with Analysis* floe in the Orion UI,
you will be presented with a job form with parameters to select.
In Figure `STMD Job Form for ligand 35 (6 poses)` you can see how we filled out
the key fields of that form for the ligand 35 6-pose case described below.

.. figure_STMD_jobForm:

.. figure:: ./images/STMD_jobForm_6poses.png
   :width: 800px
   :align: center
   :alt: STMD Job Form for ligand 35 (6 poses)

   **Key fields of STMD Job Form for ligand 35 (6 poses)**

Aside from the essential user-defined parameters relating to jobname,
input (protein and ligand datasets as described above), and
output (output and failure dataset names),
all other parameters have defaults preset to values that
we feel are suitable for the non-expert MD user
(or expert user for that matter) so launching the floe at this point is reasonable.
That said, some of the other top-level parameters are worth considering:

    * Flask_title (no default): Here is where you can put a handy short name for the protein to use in molecule titles (e.g. "Bace" instead of "beta-secretase").

    * Charge_ligands (default *True*): If your input ligands already have good atomic partial charges (e.g. `RESP` or `AM1-BCC_ELF10`), set this to *False* to have the floe use the existing ligand charges.

    * Ligand_forcefield (default *OpenFF1.2*): This forcefield choice has a strong impact on the results. We recommend the most recent version of the OpenFF force field from the *Open Force Field Initiative*.

    * Md_engine (default *OpenMM*): Gromacs is the other alternative but we recommend OpenMM because HMR works with it but not with Gromacs.

    * Hmr: Hydrogen Mass Repartitioning (HMR) gives a two-fold speedup and reduces cost. We recommend leaving it on.

We make the other top-level parameters available for expert users.

Accessing and Understanding the Results
---------------------------------------

The results from the STMD floe are accessed via two main avenues:
through the job output in the `Jobs` tab in Orion's `Floe` page, and
through orion's `Analyze` page.
We will look at the results of two jobs run on
the same MCL1 ligand; in the first case the input ligand had only a
single pose and in the second case it had six slightly different poses.

MCL1 ligand 35: single input pose
---------------------------------
First we will look at the results of the single-pose run.
In the `Jobs` tab in Orion's `Floe` page,
having selected the job name for your STMD job, you should land on
the job results page.
The left panel contains the usual orion job information from the run,
and the right panel has two tabs at the top if the run was not successful
or three tabs at the top if it was... we will focus on success here!
Selecting the third tab called *FLOE REPORT* should give you a
page looking similar to Figure `STMD Job results page for a single pose of an MCL1 ligand`.

.. figure_STMD_lig35_jobResults1pose:

.. figure:: ./images/STMD_JobResults_1pose.png
   :width: 1000px
   :align: center
   :alt: STMD Job results page for a single pose of an MCL1 ligand

   **STMD Job results page for a single pose of an MCL1 ligand**

The floe report shows a tile for each MD simulation, here there was
only one ligand in the input file.
The atom colors correspond to calculated B-factors, similar to Xray
B-factors, depicting the mobility of those atoms in the active site
over the course of the MD trajectory.
This gives an immediate read-out on how much various fragments of
the ligand were moving around in the active site. As a general principle
greater movement suggests that that fragment is not as tightly bound
in the active site, but inferences are only qualitative. Certainly
fragments hanging out in water of even a tightly bound inhibitor will be expected
to be more mobile than the buried parts.
Other information on each tile is:

    * The ligand name.

    * The number of clusters formed by clustering the ligand positions in the MD trajectory.

    * The Boltzmann-weighted MMPBSA score for ligand binding over the trajectories for all poses.

Clicking on the tile drills down into the detailed analysis of that simulation,
resulting in Figure `Detailed results for ligand 35 (single pose)`:


.. figure_STMD_lig35_interactiveSVG1pose:

.. figure:: ./images/STMD_interactiveSVG_1pose.png
   :width: 1000px
   :align: center
   :alt: Detailed results for ligand 35 (single pose)

   **Detailed results for ligand 35 (single pose)**

In the graphic we see a 2D representation of the ligand binding
interactions for the whole trajectory, with the default display
of the `Overall` tab at the top of the graphic. It is an interactive
graphic: selecting the `Cluster 0` tab in blue or the `Cluster 1` tab
in green will change the binding
interaction representation to that corresponding to the selected cluster.
Hovering over one of the interaction in the diagram lights up a
strip chart on the right-hand side grey arrow showing the occupancy
of that interaction over the course of the trajectory.
Within the heavy frame of the graphic, we see that the interactive
graph is on `interactions`; selecting `torsions` changes the depiction
to show a heavy black dot in each rotatable bond. Hovering over one
of these shows a radial bar graph of the occupancy of the torsion on
the right-hand side. Selecting `B-factor` yields a depiction of the
calculated B-factors for the selected cluster as in the parent tile,
but additionally shows the calculated B-factor for each active site
amino acid close to the ligand. To the right of the graphic is
information about the clustering of the ligand trajectory, including
a table giving the ensemble average MMPBSA energy (with standard error)
for each cluster. These averages are used to compute the Boltzmann-weighted
average for the ligand as a whole. Note that cluster 1 (green), the low
occupancy cluster, is much less stable than cluster 0 (blue), so the
Boltzmann-weighted result represents cluster 0 completely.

Scrolling down exposes a strip chart and two tables detailing relevant
analyses of the trajectories for all poses of the ligand.
The strip chart for ligand 35 (single pose) is shown
in Figure `Strip Chart results for ligand 35 (single pose)`:

.. figure_STMD_lig35_stripChart1pose:

.. figure:: ./images/STMD_stripChart_1pose.png
   :width: 800px
   :align: center
   :alt: Strip Chart results for ligand 35 (single pose)

   **Strip Chart results for ligand 35 (single pose)**

The strip chart shows a time course over the MD trajectory,
maintaining always the same color scheme as in the interactive graphic:
blue and green for cluster 0 and 1, respectively.
Additionally, cluster outliers, which are ligand configurations
that do not belong to any cluster, are shown in black.
The chart simply shows the cluster occupancy of each frame,
telling us that the trajectory started out in the blue Cluster 0,
then transitioned to the green Cluster 1 late in the trajectory.
From this sampling, it appears Cluster 0 is the predominant and
preferred cluster.

The two tables below the strip chart, shown in
`Cluster/Pose information for ligand 35 (single pose)`
describe a relationship
between each cluster found in the MD for the ligand and the
starting poses.

.. figure_STMD_lig35_tables1pose:

.. figure:: ./images/Tables_1Pose.png
   :width: 1000px
   :align: center
   :alt: Cluster/Pose information for ligand 35 (single pose)

   **Cluster/Pose information for ligand 35 (single pose)**

With only one pose used for this run the tables
are terse, but below when we look at 6 input poses for the
same ligand they will be more informative. The upper table
"Cluster Percentage by Starting Pose" simply describes the
occupancy that we see in the strip chart: the ligand spends
71% of its time in cluster 0 and 8% in cluster 1. The second
table describes how closely each cluster stays to the
starting pose: the blue Cluster 0 sticks closely
to the initial pose (1.13 |A| RMSD), whereas the green Cluster 0
has moved somewhat farther away ( 2.72 |A| RMSD).
This tells us the predominant and preferred blue Cluster 0
stays close to the initial pose.


MCL1 ligand 35: 6 input poses
-----------------------------
Now we will look at the results of another run on the same ligand 35,
but this time with 6 different input poses: 3 related poses with the
methyl "up" in the upper panel of Figure `Input poses for the 6-pose run` and
3 related poses with the methyl "down" in lower panel of the same Figure.
The "up" and "down" poses are only differentiated in the Figure for
clarity; in the input file all 6 poses are together as the 6 conformers
of the ligand 35 molecule. Poses 0, 3, and 5 have the methyl "down" and
poses 1, 2, and 4 have the methyl "up"... this will be important later.
The question we might be asking here is whether
the "up" methyl or "down" methyl is preferred, and which of the input
poses (if any) is preferred. And of course we want to see if the
preferred cluster by MD still retains the binding interactions we
thought were good enough to carry ligand 35 along up to this point.

.. figure_STMD_lig35_input6poses:

.. figure:: ./images/Start3Pose_MeUp.png
   :width: 1000px
   :align: center
   :alt: Input poses for the 6-pose run up
.. figure:: ./images/Start3Pose_MeDown.png
   :width: 1000px
   :align: center
   :alt: Input poses for the 6-pose run

   **Input poses for the 6-pose run: 3 with the methyl "up" (top) and 3 with the methyl "down" (bottom)**

Once the run is completed, again we go to the job results page,
not shown here because it is so similar to what we saw with the single-pose example
in Figure  `STMD Job results page for a single pose of an MCL1 ligand` (above).
Selecting the third tab ("*FLOE REPORT*"),
there is still only a single tile for the single ligand; the results
for all 6 poses have been aggregated and analyzed together for that
ligand.
The atom colors corresponding to the calculated B-factors will often
be a lot "hotter" (more red) for multiple-pose inputs because trajectories
for diverse poses are aggregated together, often giving higher per-atom
fluctuations.
Click on the tile to drill down into the detailed analysis,
resulting in Figure `Detailed results for ligand 35 (6 poses)`:

.. figure_STMD_lig35_interactiveSVG6poses:

.. figure:: ./images/STMD_interactiveSVG_6Poses.png
   :width: 1000px
   :align: center
   :alt: Detailed results for ligand 35 (single pose)

   **Detailed results for ligand 35 (single pose)**

Overall it looks quite similar to the single-pose case; although
the 2D representation shows a different orientation the binding
interactions are the same. There are still two clusters, but now
the clusters are very different from the single-pose case,
which will emerge as we look at the results in more detail.
Look to the right of the graphic at the table giving
the ensemble average MMPBSA energy (with standard error)
for each cluster. We see that both clusters have low MMPBSA
energies, now with the green cluster 1 slightly lower energy than
the blue cluster 0.

Scrolling down to the strip chart, shown below in
Figure `Strip Chart results for ligand 35 (6 poses)`,
we see the time course over the MD trajectories for all starting
poses concatenated and analyzed together.
The strip chart and the table below it (table `Cluster Percentage by
Pose for ligand 35 (6 poses)` both point to a clear grouping by pose:
poses 0, 3,and 5 only show cluster 0 occupancy (blue), and poses 1, 2, and 4
only cluster 1 occupancy (green).

.. figure_STMD_lig35_stripChart6poses:

.. figure:: ./images/STMD_stripChart_6Poses.png
   :width: 800px
   :align: center
   :alt: Strip Chart results for ligand 35  (6 poses)

   **Strip Chart results for ligand 35  (6 poses)**

.. figure_STMD_lig35_tableClusPercent6Poses:

.. figure:: ./images/TableClusPerct_6Pose.png
   :width: 800px
   :align: center
   :alt: Cluster Percentage by Pose for ligand 35 (6 poses)

   **Cluster Percentage by Pose for ligand 35 (6 poses)**

The former poses correspond to the
methyl "down" starting poses and the latter to the methyl "up" starting
poses, which we can confirm in the Orion 3D page. While the short trajectories
in this run (2 ns for each pose) do not allow interconversion between
methyl "up" and "down" poses, it appears that the 3 poses in each category
have collapsed to a single cluster. How close is the cluster to any of
the starting poses? This answered by the final table in the Floe
Report, Table `Cluster RMSD from Pose for ligand 35 (6 poses)`

.. figure_STMD_lig35_tableClusRMSD6Poses:

.. figure:: ./images/TableClusRMSD_6Pose.png
   :width: 800px
   :align: center
   :alt: Cluster RMSD from Pose for ligand 35 (6 poses)

   **Cluster RMSD from Pose for ligand 35 (6 poses)**

This table confirms that cluster 0 is quite close to the starting
poses (0, 3, and 5) that contributed to it, though slightly closer
to Pose 0. Cluster 1 is still within 2 |A| of all six poses, but
closest to Pose 1 out of all.

We can visually confirm this by selecting the output dataset (in
the "Data" tab of Orion) and then going to the "3D" tab. Under the
list of structures for ligand 35, the starting poses appear as
"Conformer (6)", the average structures for the clusters
under "Average 35" with the average ligands under "Conformers (2)"
and the average proteins underneath that. Selecting starting poses
0, 3, and 5 with the average ligand and protein for cluster 0 (blue)
gives the upper panel in Figure `Starting Poses and Cluster Averages
for ligand 35`. Selecting starting poses
1, 2, and 4 with the average ligand and protein for cluster 1 (green)
gives the lower panel.

.. figure_STMD_lig35_tableClusRMSD6Poses:

.. figure:: ./images/Final3Pose_MeDown.png
   :width: 800px
   :align: center

.. figure:: ./images/Final3Pose_MeUp.png
   :width: 800px
   :align: center
   :alt: Starting Poses and Cluster Averages for ligand 35

   **Starting Poses and Cluster Averages for ligand 35**

These visually confirm what we had seen emerging from the analysis:
the 6 poses collapse into a single consensus methyl "up" and methyl
"down" pose. Cluster 0 lies close to one of the starting poses, but
Cluster 1 lies in between two of the starting poses. The ensemble
MMPBSA energies of the two clusters are very similar, so we cannot
pick a preferred binding mode... perhaps both would occur.


Analyzing a Set of Ligands
--------------------------
Finally we will look at how to visualize the results for the entire
MCL1 dataset of 10 ligands, each with multiple input poses, all
run in the same job in the "Short Trajectory MD with Analysis" floe.
Selecting the output dataset in the "Data" tab and moving to the
"Analyze" tab, the results for the entire dataset can be viewed at
once as in Figure `Analyze page for MCL1 dataset`:

.. figure_STMD_lig1b_analyze:

.. figure:: ./images/STMD_MCL1_analyze.png
   :width: 1000px
   :align: center
   :alt: Analyze page for MCL1 dataset

   **Analyze page for MCL1 dataset**

There are a lot of results showing in this page, encompassing
both numerical and 3D information. The 3D info is brought in by
selecting `Analyze 3D` under the `Layout` pull-down menu at the
top right. The axes of the scatterplot were selected to display
the experimental deltaG (included as an SD tag on the input
ligands) on the x axis and the Boltzmann-weighted emsemble MMPBSA value on the y axis.
Scrolling down the spreadsheet to ligand 35 and selecting that
row, the 3D visualizer jumps to a series of entries relating to
ligand 35 and the point in the scatter plot corresponding to
ligand 35 is highlighted.
In the 3D window, the initial input poses for ligand 35 are shown in gold.
Expanding the menu under `Average 35` allows us to turn on the
average structure for Clusters 0 and 1, again maintaining
the colors for each of blue and green, respectively.
Just above `Average 35` are the corresponding average protein structures,
in matching color, to go with the average ligand for each cluster.
This way we can compare the poses to the representative
average for each cluster, helping us to evaluate and prioritize that ligand.
To call up the detailed MD analysis once again, go to the spreadsheet
row for ligand 35, and under the column titled `Floe_report_URL`
click on the little square to open up another tab in your
browser with the same detailed analysis floe report for ligand 35.

There is a lot of information to look at in the results from
the *Short Trajectory MD with Analysis* floe, but this should get
you started. We emphasize that a lot of the analyses can only
be interpreted qualitatively at this stage, but nevertheless
we feel that the sampling of both protein and ligand configurations
at physiological temperatures in the context of explicit water solvation
can help validate the initial input pose(s).
